Join to access to all OVN content. Join for Free

Results for 'tumor agnostic'

Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care

Thought Leadership, Oncology

From biomarker-driven breakthroughs to AI-powered early detection and a renewed commitment to equity and patient centricity, the past 12 months have seen major strides across cancer research, treatment, and communication. At Inizio, we’ve had a front-row seat to this transformation, supporting…

May 16th • 5 mins read

The FDA Oncology Center of Excellence and Precision Medicine
OVN Avatar Kirsten B Goldberg, Gideon M Blumenthal, Amy E McKee and Richard Pazdur
The FDA Oncology Center of Excellence and Precision Medicine

Biomarkers, drugs, hematology, medicine, oncology, precision medicine, regulation

The FDA is exploring real-world evidence to enhance understanding of the long-term safety and efficacy of oncology drugs. Initiatives like the Information Exchange and Data Transformation initiative are building infrastructure for big-data analytics. Additionally, patient-focused programs aim to inc…

Nov 6th • 3 mins read

Related Topics

Meet Our Innovation Partners

Loading partners...